Johnson & Johnson to initiate its first vaccine study for adolescents in fall | The Hill: Healthcare Policy

Johnson & Johnson plans to initiate its first study of its COVID-19 involving adolescents aged 12-17 years old in the fall, an executive said Wednesday during a Johns Hopkins University of Washington event.The study will be the first of four...